In earnings calls, diabetes tech companies had less to say about tariffs and focused more on future growth.

DexCom, Inc. DXCM is well-poised for growth in the coming quarters, backed by its strong product portfolio. A strong ...

DexCom Inc. closed 34.58% short of its 52-week high of $132.26, which the company reached on May 17th.

DexCom, Inc. (DXCM), with a market cap of $33.9 billion, is a leading medical device company specializing in continuous ...

Shares of DexCom Inc. DXCM shed 1.11% to $84.11 Tuesday, on what proved to be an all-around mixed trading session for the ...

SAN DIEGO, May 13, 2025--(BUSINESS WIRE)--DexCom, Inc. (NASDAQ: DXCM), the global leader in real-time continuous glucose biosensing, today announced the promotion of Jake Leach to president ...

DexCom (DXCM) appears an attractive pick, as it has been recently upgraded to a Zacks Rank #2 (Buy). This upgrade is essentially a reflection of an upward trend in earnings estimates -- one of the ...

(RTTNews) - DexCom, Inc. (DXCM) announced Tuesday the promotion of Jacob Leach to president, in addition to his current role as chief operating officer, which he has held since 2022. With more ...

Ken Griffin, the founder of Citadel, is an influential albeit controversial figure in the investment industry.

In an exclusive interview, Nick Jonas shares what it's like to have his brothers' support as he takes on solo projects, like ...